W F McGhan, B A Briesacher. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisDrug CostsEconomics, PharmaceuticalHealth Care CostsHumansModels, EconomicOutcome Assessment, Health Care/economicsQuality of Life
Year: 1994 PMID: 10155270 DOI: 10.2165/00019053-199406050-00002
Source DB: PubMed Journal: Pharmacoeconomics ISSN: 1170-7690 Impact factor: 4.981